Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

4.610

-0.310 (-6.30%)

At close: May 8, 2026, 4:00 PM EDT

4.650

+0.040 (0.87%)

After-hours: May 8, 2026, 5:05 PM EDT

Cytek Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	204.17	201.49	200.45	193.02	164.04	127.95
Revenue Growth (YoY)	3.61%	0.52%	3.85%	17.67%	28.20%	37.82%
Cost of Revenue	98.61	97.03	89.35	83.59	63.06	48.81
Gross Profit	105.56	104.46	111.11	109.43	100.97	79.14
Selling, General & Admin	113.08	108.38	92.23	93.12	67.92	45.55
Research & Development	36.35	36.47	39.4	44.15	34.86	24.44
Total Operating Expenses	149.43	144.84	131.63	137.27	102.78	69.99
Operating Income	-43.87	-40.38	-20.52	-27.85	-1.8	9.16
Interest Income	2.5	2.22	5.12	6.41	4.62	0.05
Interest Expense	-1.17	-	-	-	-	-1.74
Other Non-Operating Income (Expense)	5.88	8.33	9.7	5.72	-1.56	-1.53
Total Non-Operating Income (Expense)	7.2	10.54	14.82	12.14	3.06	-3.22
Pretax Income	-36.67	-29.84	-5.7	-15.71	1.26	5.94
Provision for Income Taxes	38.06	36.7	0.32	-3.56	-1.22	2.91
Net Income	-74.73	-66.54	-6.02	-12.15	2.58	6.05
Minority Interest in Earnings	-	-	-	-	0.09	-3.03
Net Income to Common	-74.73	-66.54	-6.02	-12.15	2.58	6.05
Net Income Growth	-	-	-	-	-57.45%	88.25%
Shares Outstanding (Basic)	128	128	131	135	135	77
Shares Outstanding (Diluted)	128	128	131	135	139	82
Shares Change (YoY)	-2.31%	-2.19%	-3.45%	-2.37%	69.93%	150.13%
EPS (Basic)	-0.57	-0.52	-0.05	-0.09	0.02	-
EPS (Diluted)	-0.57	-0.52	-0.05	-0.09	0.02	-
Shares Outstanding	129.14	128.55	129.21	130.72	135.37	133.75
Free Cash Flow	-9.31	-8.77	21.85	0.63	-21.98	0.27
Free Cash Flow Growth	-	-	3352.45%	-	-	-98.05%
Free Cash Flow Per Share	-0.07	-0.07	0.17	0.00	-0.16	0.00
Gross Margin	51.70%	51.84%	55.43%	56.69%	61.56%	61.86%
Operating Margin	-21.49%	-20.04%	-10.24%	-14.43%	-1.10%	7.16%
Profit Margin	-36.60%	-33.02%	-3.00%	-6.29%	1.51%	2.37%
FCF Margin	-4.56%	-4.35%	10.90%	0.33%	-13.40%	0.21%
EBITDA	-31.97	-28.41	-10.03	-18.62	3.86	10.4
EBITDA Margin	-15.66%	-14.10%	-5.01%	-9.64%	2.35%	8.13%
EBIT	-43.87	-40.38	-20.52	-27.85	-1.8	9.16
EBIT Margin	-21.49%	-20.04%	-10.24%	-14.43%	-1.10%	7.16%
Effective Tax Rate	-103.77%	-122.98%	-5.61%	22.67%	-97.14%	49.02%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q